Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00136006
Other study ID # P05-0061
Secondary ID 05-0965
Status Active, not recruiting
Phase N/A
First received August 25, 2005
Last updated January 30, 2013
Start date August 2005
Est. completion date December 2013

Study information

Verified date January 2013
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Observational

Clinical Trial Summary

This is a study of the lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1000
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria:

- 40 years of age and older

- Both sexes

- Random sample of population

Exclusion Criteria:

- Contraindication for lung function testing and serious life threatening illness.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Behavioral:
Study to determine the burden of disease
Unspecified

Locations

Country Name City State
Canada St.Paul's Hospital/Providence Health Care Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lung health Lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease 10 years No
See also
  Status Clinical Trial Phase
Withdrawn NCT01416701 - Vitamin D and Chronic Obstructive Lung Disease Phase 4
Completed NCT01362855 - Advance Care Planning Evaluation in Hospitalized Elderly Patients
Completed NCT00202150 - Primary Care Management/Action Plans for Advanced Chronic Diseases Phase 2/Phase 3
Recruiting NCT05227547 - Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease N/A
Withdrawn NCT02273349 - Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency N/A
Completed NCT00018408 - Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT02987439 - COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD N/A
Completed NCT01950936 - Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) Phase 2/Phase 3
Completed NCT01404000 - Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal Phase 2
Terminated NCT03811158 - The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD N/A
Recruiting NCT01631162 - The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples N/A
Completed NCT01596023 - Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients N/A
Completed NCT01347931 - In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency N/A
Terminated NCT01712854 - Effects of Symbicort on the Ventilatory Kinematics Phase 4
Completed NCT02462343 - Comparison of the Two and Six- Minute Walk Tests in Evaluating Oxygen Desaturation in Patients With Severe COPD N/A
Recruiting NCT06090149 - Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients N/A
Recruiting NCT02778802 - Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR N/A
Enrolling by invitation NCT02278107 - Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease N/A
Completed NCT01614951 - The Pulmonary Protection Trial Phase 4
Completed NCT01787097 - Effect of Symbicort ® on GR in Sputum in COPD Phase 4